HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Wilensky Selected Research

Type 2 Diabetes Mellitus (MODY)

6/2007A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
3/2006Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Wilensky Research Topics

Disease

21Myocardial Infarction
01/2017 - 06/2002
14Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2006
10Atherosclerosis
01/2013 - 03/2007
8Hypercholesterolemia
01/2013 - 07/2003
7Thrombosis (Thrombus)
01/2017 - 05/2002
7Atherosclerotic Plaque (Atheroma)
04/2016 - 06/2005
7Hyperplasia
12/2011 - 05/2002
6Acute Coronary Syndrome
11/2013 - 12/2006
5Diabetes Mellitus
01/2017 - 08/2006
4Inflammation (Inflammations)
02/2015 - 05/2008
4Coronary Disease (Coronary Heart Disease)
11/2013 - 07/2003
3Hemorrhage
01/2020 - 03/2003
3ST Elevation Myocardial Infarction
11/2016 - 12/2008
3Peripheral Arterial Disease
02/2016 - 04/2011
3Pathologic Constriction (Stenosis)
03/2011 - 07/2003
3Unstable Angina
04/2007 - 06/2002
2Fibrosis (Cirrhosis)
01/2020 - 01/2020
2Infarction (Infarctions)
02/2014 - 05/2006
2Heart Failure
11/2013 - 01/2006
2Chronic Renal Insufficiency
12/2011 - 11/2003
2Neointima
03/2011 - 03/2003
2Vascular System Injuries
01/2011 - 05/2002
2Hypertension (High Blood Pressure)
11/2009 - 09/2009
2Cardiovascular Diseases (Cardiovascular Disease)
10/2008 - 12/2005
2Stroke (Strokes)
10/2008 - 03/2005
2Type 2 Diabetes Mellitus (MODY)
06/2007 - 03/2006
2Stable Angina
12/2006 - 08/2006
2Vascular Diseases (Vascular Disease)
12/2005 - 03/2005
1End Stage Liver Disease
01/2020
1Eye Diseases (Eye Disease)
01/2017
1Ganglion Cysts (Ganglion)
01/2017
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2017
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Macular Degeneration (Age-Related Maculopathy)
01/2017
1Right Ventricular Dysfunction
06/2014
1Pulmonary Embolism
06/2014
1Aneurysm (Aneurysms)
04/2014
1Necrosis
03/2014
1Hypoxia (Hypoxemia)
03/2014
1Chronic Limb-Threatening Ischemia
03/2014
1Ischemia
03/2014
1Ventricular Remodeling
02/2014
1Cardiomyopathies (Cardiomyopathy)
11/2013
1Alzheimer Disease (Alzheimer's Disease)
01/2013
1Flushing
04/2012
1Hyperglycemia
10/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2011

Drug/Important Bio-Agent (IBA)

81-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
02/2015 - 03/2007
4darapladibIBA
01/2017 - 10/2008
4LipidsIBA
04/2016 - 06/2005
4CholesterolIBA
11/2013 - 07/2003
4MetalsIBA
12/2011 - 04/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2011 - 07/2003
3Pharmaceutical PreparationsIBA
01/2017 - 01/2010
3Peptides (Polypeptides)IBA
01/2017 - 01/2013
3Transcription Factors (Transcription Factor)IBA
03/2014 - 03/2006
3HDL LipoproteinsIBA
11/2013 - 01/2011
3Insulin (Novolin)FDA Link
09/2009 - 06/2007
2AnticoagulantsIBA
06/2014 - 03/2003
2Proteins (Proteins, Gene)FDA Link
02/2014 - 11/2010
2Lipoproteins (Lipoprotein)IBA
11/2013 - 04/2006
2Paclitaxel (Taxol)FDA LinkGeneric
12/2011 - 10/2011
2Pioglitazone (Actos)FDA Link
03/2011 - 01/2011
2Phenobarbital (Luminal)FDA Link
01/2011 - 02/2003
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2010 - 11/2009
2CalciumIBA
01/2010 - 04/2006
2Biological ProductsIBA
01/2010 - 03/2007
2omega-Chloroacetophenone (Mace)IBA
12/2005 - 09/2003
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
03/2003 - 05/2002
1Glial Fibrillary Acidic ProteinIBA
01/2017
1ClaudinsIBA
01/2017
1Immunoglobulin G (IgG)IBA
01/2017
1Tight Junction ProteinsIBA
01/2017
1OccludinIBA
01/2017
1Retinaldehyde (Retinal)IBA
01/2017
1EverolimusFDA Link
04/2014
1Eosine Yellowish-(YS) (Eosin)IBA
03/2014
1DNA (Deoxyribonucleic Acid)IBA
03/2014
1AntibodiesIBA
03/2014
1Hematoxylin (Haematoxylon)IBA
03/2014
1ChemokinesIBA
02/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2014
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
02/2014
1ElastinIBA
02/2014
1Messenger RNA (mRNA)IBA
02/2014
1Peptide Hydrolases (Proteases)FDA Link
02/2013
1Amyloid (Amyloid Fibrils)IBA
01/2013
1Niacin (Nicotinic Acid)FDA LinkGeneric
04/2012
1HDL CholesterolIBA
01/2011

Therapy/Procedure

18Percutaneous Coronary Intervention
01/2020 - 06/2002
14Stents
01/2017 - 05/2002
9Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2016 - 08/2002
7Therapeutics
02/2015 - 06/2006
5Drug-Eluting Stents
01/2017 - 06/2006
2Thrombolytic Therapy
12/2015 - 06/2014
1Blood Transfusion (Blood Transfusions)
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2016
1Lasers (Laser)
03/2014
1Secondary Prevention
02/2014
1Ligation
02/2014